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Abstract 
The one-pot three component condensation of catechol and resorcinol with aromatic aldehydes and amides, 
thioamides such as urea, thiourea, thiosemicarbazide and acetamide under solvent free and neutral conditions to 
afford urea, thiourea and amide derivatives in high yields. The antitumor activity of some of the synthesized 
products was tested. 
Keywords: Three component condensation; 4H-benzo[e]-[1,3]oxazin-7-ol; Dioxoindenylurea; Antitumor 
activity.  
 
1. Introduction 
Multi-component condensation reactions have a wide range of applicability in the field of synthetic organic 
chemistry and they constitute an especially attractive synthetic strategy because they provide easy and rapid 
access to large libraries of organic compounds with diverse substitution patterns. These are one pot reactions, 
they are easier to carry out than multistep syntheses, and their products are formed in a single step. Diversity can 
be achieved simply by varying each component (Khazaei et al. 2013; Verma et al. 2012; Shirini et al.  2013; 
Kouznetsov et al. 2012), In the past few years, combinatorial methods using multi-component reactions have 
been closely examined as fast and convenient solutions for the synthesis of diverse classes of compounds. 
Recently, this strategy became important in drug discovery in the context of synthesis of biologically active 
compounds. This method increases the efficiency of the reactions and decreases the number of laboratory 
operations along with solvents and chemicals used. Also, it reduces reaction time and facilitates the yield of 
products more than the normal multistep methods. 
Also, a number of reports have recently highlighted diarylureas as potential antiproliferative agents against 
melanoma cell line. Sorafenib (Nexavar) is a diarylurea derivative that has been exclusively used in clinical trials 
(El Gamal et al. 2011), Sorafenib was subsequently recognized as exhibiting useful receptor tyrosine kinase 
poly-pharmacology, particularly inhibition of VEGF receptor, PDGF receptor, c-KIT and FLT3 kinases (El 
Gamal et al. 2011), Leading to drug approval for the treatment of renal cell cancers. N-(4-tert-Butylphenyl)-N'-
(2-chloroethyl) urea shows potent anticancer activity (Mounetou et al. 2001; Mounetou et al. 2003), Urea 
derivative such as diuron is used as herbicides (Proctor et al. 2002), Thienopyridines including their 1,3-
diarylurea derivatives have shown different biological activities namely as antitumor agents (Hayakawa et al. 
2004), and receptor tyrosine kinase inhibitors (Heyman et al. 2007 ). 
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These reports Encouraged us to synthesis a novel urea, thiourea and amide derivatives through three component 
one pot reactions to study the antitumor activity of some of the synthesized products. 
2. Results and discussion 
The new derivatives were prepared according to the reaction sequences depicted in Schemes 1-4. Fusion of 
equimolar amounts of anisaldehyde, resorcinol or catechol and acetamide at 150-180◦C afforded N-[(2,4-
dihydroxyphenyl)(4-methoxyphenyl)methyl]acetamide (1a), N-[(3,4-dihydroxyphenyl)(4-
methoxyphenyl)methyl]acetamide (1b), respectively. However fusion of anisaldehyde, resorcinol and acetamide  
in the presence of POCl3 gave 4-(4-methoxyphenyl)-2-methyl-4H-benzo[e]-[1,3]oxazin-7-ol (2).  
Interestingly, compound (2) can also be prepared through an alternative route via the reaction of 1a with POCl3, 
which can be proved by m.mp and I.R. 
The formation of (1a) and (2) can be explained according to the following proposed mechanism, Figure 1. 
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 With a similar mechanism fusion of anisaldehyde, resorcinol or catechol and urea gave 1-[(2,4-
dihydroxyphenyl)(4-methoxyphenyl)methyl]urea (3a), 1-[(3,4-dihydroxyphenyl)(4-methoxyphenyl)methyl]urea 
(3b), respectively. 
However, fusion of anisaldehyde, resorcinol and thiosemicarbazide gave 4-[(2,4-dihydroxyphenyl)(4-
methoxyphenyl)methyl]thiosemicarbazide (4a). However reflux of anisaldehyde, catechol and thiosemicarbazide 
in AlCl3/ethanol gave 4-[(3,4-dihydroxy-phenyl)(4-methoxyphenyl)methyl]thiosemicarbazide (4b). 
On the other hand, fusion of anisaldehyde, catechol and thiourea gave1-[(2,4-dihydroxy-phenyl)(4-
methoxyphenyl)methyl]thiourea (5). 
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Interestingly, fusion of catechol, N,N-dimethylbenzaldehyde with acaetamide gave N-[(3,4dihydroxyphenyl)(4-
(dimethylamino)phenyl)methyl]acetamide (6), with urea gave 1-[(3,4-dihydroxyphenyl)(4-
(dimethylamino)phenyl)methyl]urea (7), while with thiourea gave 1-[(3,4-dihydroxyphenyl)(4-
(dimethylamino)phenyl)methyl]thiourea (8), respectively. 
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 Finally, fusion of catechol, urea with ninhydrin at 160oC gave 1-[2-(3,4-dihydroxyphenyl)-1,3-dioxo-2,3-
dihydro-1H-inden-2-yl]urea(9). 
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3. Experimental 
All Melting points were determined on an electrothermal (9100) apparatus and are uncorrected. The infrared 
spectra (ν in cm-1) were recorded using KBr disks on a Pye Unicam SP-3-300 infrared spectrophotometer in the 
Central laboratory of Ain Shams University. Mass spectra were recorded on a GC-MS 2010 Shimadzu in Cairo 
University. The NMR spectra were recorded on a Varian Mercury VX-300 NMR spectrometer in DMSO-d6 as 
solvent and TMS as internal standard in Laboratoire Chimie et Procédés, DCSO, UMR 7652, Ecole Nationale 
Supérieure de Techniques Avancées (ENSTA), Paris, France, chemical shifts are quoted in δ (ppm). TLC was 
carried out for monitoring of the progress of all reactions and homogenity of the synthesized compounds. TLC 
was determined using TLC aluminium sheets silica gel F254 (Merck). 
3.1 General procedure for the synthesis of compounds (1-9)  
Resorcinol and catechol (0.01mol), anisaldehyde, N,N-dimethylbenzaldehyde and ninhydrin (0.01mol) and 
acetamide, urea, thiosemicarbazide and thiourea (0.01mol), were mixed in dry flask. The reaction mixture was 
fused at 150-180◦C in an oil bath for 4-6 hr. The products were scratched by water or boiling in ethanol and then 
isolated by filtration. The products were washed by boiling ethanol (2x50 ml) and then by boiling dioxane (2x50 
ml), filtered and dried.   
3.1.1 N-[(2,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]acetamide (1a) 
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Red crystals; yield (75%), mp: >300°C; I.R: 1605 (CO), 3291-3365 (NH, OHs), MS: m/z, 287(M·+, 0.50%), 
288(M+1, 0.35%), 57(100%). Anal.Calcd. for C16H17NO4 (287.31): C, 66.89; H, 5.96; N, 4.88. Found: C, 67.22; 
H, 5.84; N, 4.72. 
3.1.2 N-[(3,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]acetamide (1b) 
Brown powder; yield (59%), mp: >300°C; I.R: 1608 (CO), 3201-3475 (NH, OHs); ), 1H-NMR: 8.65 (s, 2H, OH), 
7.4 (s, 1H, NH), 7.25-6.6 (m, 7H, ArH), 6.3 (s, 1H, CH), 3.65 (s, 3H, OCH3), 2.5 (s, 3H, COCH3), MS: m/z, 
287(M·+, 72.45%), 288(M+1, 64.29%), 87(100%). Anal.Calcd. for C16H17NO4 (287.31): C, 66.89; H, 5.96; N, 
4.88. Found: C, 66.68; H, 6.02; N, 4.71. 
3.1.3 1-[(2,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]urea (3a) 
Reddish brown powder; yield (52%), mp: >300°C; I.R: 1608 (CO), 3221-3399 (NH, OHs, NH2), MS: m/z, 
288(M·+, 14.4%), 289(M+1, 73.3%), 141(100%). Anal.Calcd. for C15H16N2O4 (288.3): C, 62.49; H, 5.59; N, 
9.72. Found: C, 62.21; H, 5.72; N, 9.87. 
3.1.4 1-[(3,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]urea (3b) 
Reddish brown powder; yield (66%), mp: 158°C; I.R: 1663 (CO), 3267-3473 (NH, OHs, NH2), 1H-NMR: 8.6 (s, 
2H, OH), 7.9 (s, 1H, NH), 7.4-6.25 (m, 7H, ArH), 5.45 (s, 1H, CH), 5.2 (s, 2H, NH2), 3.4 (s, 3H, OCH3), MS: 
m/z, 288(M·+, 48.82%), 289(M+1, 47.24%), 69(100%). Anal.Calcd. for C15H16N2O4 (288.3): C, 62.49; H, 5.59; 
N, 9.72. Found: C, 62.32; H, 5.51; N, 9.59. 
3.1.5 4-[(2,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]thiosemicarbazide (4a) 
Red powder; yield (56%), mp: > 300°C; I.R: 1202- 3430 (NH, OHs, NH2), 1H-NMR: 11.35 (s, 2H, OH), 
8.5&8.4 (s & t, 2H, NH), 8.4-6.1 (m, 7H, ArH), 5.6 (s, 1H, CH), 5.45 (d, 2H, NH2), 3.65 (s, 3H, OCH3), MS: 
m/z, 319(M·+, 84.9%), 320(M+1, 94.2%), 321(M+2, 81.4%), 171(100%). Anal.Calcd. for C15H17N3O3S (319.38): 
C, 56.41; H, 5.37; N, 13.16; S, 10.04. Found: C, 56.22; H, 5.38; N, 13.04. 
3.1.6 1-[(2,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]thiourea (5) 
Reddish brown powder; yield (57%), mp: > 300°C; I.R: 1222-3449 (NH, OHs, NH2), MS: m/z, 304(M·+, 
67.07%), 305(M+1, 75.61%), 306(M+2, 63.41%), 174(100%). Anal.Calcd. for C15H16N2O3S (304.36): C, 59.19; 
H, 5.30; N, 9.20; S, 10.54. Found: C, 59.03; H, 5.20; N, 9.41. 
3.1.7 N-[(3,4-Dihydroxyphenyl)(4-(dimethylamino)phenyl)methyl]acetamide (6) 
Grey powder; yield (53%), mp: >300°C; I.R: 1609(CO), 1243-3368(NH, OHs), MS: m/z, 300(M·+, 60.0%), 
301(M+1, 66.3%), 302(M+2, 63.2%), 52(100%). Anal.Calcd. for C17H20N2O3 (300.35): C, 67.98; H, 6.71; N, 
9.33. Found: C, 67.62; H, 6.70; N, 9.46. 
3.1.8 1-[(3,4-Dihydroxyphenyl)(4-(dimethylamino)phenyl)methyl]urea (7) 
Grey powder; yield (63%), mp: 120°C; I.R: 1647(CO), 1223-3349 (NH, OHs, NH2), MS: m/z, 301(M·+, 9.9%), 
302(M+1, 5.8%), 303(M+2, 6.1%), 121(100%). Anal.Calcd. for C16H19N3O3 (301.34): C, 63.77; H, 6.36; N, 
13.94. Found: C, 63.52; H, 6.28; N, 14.13. 
3.1.9 1-[(3,4-Dihydroxyphenyl)(4-(dimethylamino)phenyl)methyl]thiourea (8) 
Grey powder; yield (70%), mp: 188°C; I.R: 1203-3335 (NH, OHs, NH2), MS: m/z, 317(M·+, 33.3%), 318(M+1, 
35.8%), 63(100%). Anal.Calcd. for C16H19N3O2S (317.41): C, 60.54; H, 6.03; N, 13.24; S, 10.10. Found: C, 
60.42; H, 5.94; N, 13.40. 
3.1.10 1-[2-(3,4-Dihydroxyphenyl)-1,3-dioxo-2,3-dihydro-1H-inden-2-yl]urea (9) 
Brown powder; yield (65%), mp: >300°C; I.R: 1640, 1666 (COs), 1211-3337(NH, OHs, NH2), MS: m/z, 
312(M·+, 28.5%), 313(M+1, 25.1%), 57(100%). Anal.Calcd. for C16H12N2O5 (312.28): C, 61.54; H, 3.87; N, 
8.97. Found: C, 61.33; H, 3.82; N, 9.13. 
3.2 Synthesis of 4-(4-Methoxyphenyl)-2-methyl-4H-benzo[e][1,3]oxazin-7-ol (2) 
Resorcinol (1.1g, 0.01mol), anisaldehyde (1.56g, 0.01mol) and acetamide (0.6g, 0.01mol) and POCl3 (10 ml) 
were mixed. The reaction mixture was heated on water bath for 2 h. The solution was poured onto [crushed 
ice/HCl] with stirring. The precipitate was filtered and washed with water. The product was recrystallized from 
ethanol to give red powder. 
Authentic sample (2)  
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A mixture of 1a (2.9 g, 0.01 mol) and POCl3 (10 ml) was heated on water bath for 2 h. The solution was poured 
onto [crushed ice/HCl] with stirring. The precipitate was filtered and washed with water. The product was 
recrystallized from ethanol to give red powder. 
Yield (55%), mp: >300°C; I.R: 3403 (OH), MS: m/z, 269(M·+, 16.7%), 270(M+1, 13.9%), 271(M+2, 14.4%), 
94(100%). Anal.Calcd. for C16H15NO3 (269.3): C, 71.36; H, 5.61; N, 5.20. Found: C, 71.21; H, 5.60; N, 5.74. 
3.3 Synthesis of 4-[(3,4-Dihydroxyphenyl)(4-methoxyphenyl)methyl]thiosemicarbazide (4b) 
Catechol (1.1g, 0.01mol), anisaldehyde (1.56g, 0.01mol), thiosemicarbazide (0.91, 0.01mol), and AlCl3/ethanol 
(0.5gm/50ml) were mixed. The reaction mixture was heated on water bath for 2 h. The solution was poured onto 
[crushed ice/HCl] with stirring. The precipitated product was filtered and washed with water. The product (4b) 
was recrystallized from dioxane to give dark violet powder; yield (72%), mp: 155-157°C; I.R: 3211-3449(NH, 
OHs, NH2), MS: m/z, 319(M·+, 60.6%), 320(M+1, 19.2%), 134(100%). Anal. Calcd. for C15H17N3O3S (319.38): 
C, 56.41; H, 5.37; N, 13.16; S, 10.04. Found: C, 56.23; H, 5.40; N, 12.98. 
4. Antitumor activity studies 
4.1 Sulforhodamine-B(SRB)assay of cytotoxic activity 
MCF-7 (breast carcinoma cell line), HepG-2 (hepatocellular carcinoma cell line) were obtained frozen in liquid 
nitrogen (-180◦C) from the American type culture collection. The tumor cell lines were maintained in the 
National cancer Institute, Cairo, Egypt, by serial sub-culturing. Potential cytotoxicity of 1a and 1b were tested 
using the method of Skehan et al. 
4.2 Principle 
The sensitivity of the human tumor cell lines to thymoquinone was determined by the SRB assay. SRB is a 
brought pink aminoxanthrene dye with two sulfonic groups. It a protein stain that binds to the amino group of 
intracellular proteins under mildy acidic conditions to proceed a sensitive index of cellular protein content. 
4.3 Procedure 
1-Cells were used when 90% confluence was reached in T25 flasks. Adherent cell lines were harvested with 
0.025% trypsin. Vealrlity was determined by trypan blue exclusion using the invested microscope (Olympus 
1x70, Tokyo, Japan). 
2-Cells were seeded in 96- well microliter plates at a concentration of 5x104 – 105 cell / well in a fresh medium 
and left to attach to the plates for 24h. 
3-After 24h, cells were incubated with the appropriate concentration ranges of drugs, completed to total of 200µ 
volume / well using fresh medium and incubation was continued for 24, 48 and 72h. Cells were treated with 
vehicle alone. For each drug concentration, 4 wells were used. 
4-Following 24, 48 and 72h.Treatment, the cells were fixed with 50µl cold 50% trichloroacetic acid for 1h at 
4◦C. 
5-Wells were washed 5 times with distilled water and stained for 30 min at room temperature with 50µl 0.4% 
SRB dissolved in 1% acetic acid. 
6-The wells were then washed 4 times with 1% acetic acid. 
7-The plates were air-dried and the dye was solublized with 100µl / well or mMtris base (Ph 10.5) for 5 mm on a 
shaken (orblal shaken 0520, Boeco, Germany) at 1600 rpm. 
8-The optical density (O.D.) of each well was measured spectrophotometrically at 564 nm with an ELIZA 
microplate reader (Meler tech Σ960, U.S.A.).The mean background absorbance was automatically substracted 
and mean values of each drug concentration were calculated. The relation between survival fraction and 
compound concentration was plotted to get the survival curve of each tumor all lines (Fig.2), the IC50 values 
(the concentrations of thymoquinone required to produce 50% inhibition of cell growth (Fig.3) 
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MCF-7: (1a) MCF-7: (1b) 
 
 
HepG-2:(1a) HepG-2:(1b) 
 
 
Fig. (2): Anti-tumor cytotoxicity of different concentrations (µg/ml) of compounds 1a and 1b. Against different 
human cancer cell lines in vitro. 
4.4 Cytotoxicity against different human cancer cell lines in vitro 
For evaluation of anti-tumor cytotoxicity of compounds 1a, 1b three different human cancer cell lines were used: 
MCF-7 (breast carcinoma cell line), HepG-2 (hepatocellular carcinoma cell line). Cytotoxicity and IC50 values 
of the tested compounds are shown in Fig.2 and Fig.3. The survival fractions were gradually decreased as the 
concentration of the tested compounds was increased (table1). From figure 3, it has been shown that 1a, 1b are 
the compounds of high IC50 which means that they are effective cytotoxic drugs; accordingly these compounds 
can be used as cytotoxic drug for breast carcinoma cell and for liver carcinoma cell. 
 
                                                       MCF-7                                HepG-2 
Fig. (3): 0-10 very potent cytotoxic drug, 10-20 moderate cytotoxic drug, >20 very weak cytotoxic drug. 
Table (1): effect of some new prepared compounds on different types of tumor cells as cytotosxic drug 
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Con.µg/ml MCF-7 HepG-2 
 1a 1b 1a 1b 
0 100 100 100 100 
1.56 94.21 98.28 90.34 100 
3.125 89.02 91.87 84.14 97.92 
6.25 80.45 83.12 75.36 90.87 
12.5 67.37 69.48 61.93 76.84 
25 51.24 55.76 45.82 63.29 
50 14.78 23.82 16.46 27.31 
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